Login Register Cart 0
Generic placeholder image

Combinatorial Chemistry & High Throughput Screening

Editor-in-Chief

ISSN (Print): 1386-2073
ISSN (Online): 1875-5402

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Prognosis and Clinical Significance of Piezo2 in Tumor: A Meta-analysis and Database Validation

Author(s): Tong Liang, Junhong Wang, Chenglou Zhu, Yongli Hu, Zhenhua Gao* and Mingxu Da*

Volume 27, Issue 19, 2024

Published on: 12 February, 2024

Page: [2912 - 2920] Pages: 9

DOI: 10.2174/0113862073251440231025111358

open access plus

Abstract

Objective: The objective of this study is to assess the correlation between Piezo2 and tumors through a comprehensive meta-analysis and database validation.

Methods: Case-control studies investigating the association between Piezo2 and tumors were obtained from various databases, including China National Knowledge Infrastructure (CNKI), SinoMed, Embase, Web of Science, The Cochrane Library, and PubMed. The search was performed from the inception of each database up until May 2023. Two researchers independently screened the literature, extracted data, and assessed the quality of the included studies. Metaanalysis of the included literature was conducted using Stata 12.0 software. Additionally, the Gene Expression Profiling Interactive Analysis (GEPIA) database predicted a correlation between Piezo2 expression and prognostic value in tumor patients.

Results: A total of three studies, involving a combined sample size of 392 participants, were included in the meta-analysis. The findings revealed that the expression level of Piezo2 in tumor patients was not significantly associated with age, gender, or tumor size. However, it was found to be positively correlated with lymphatic invasion (OR = 7.89, 95%CI: 3.96-15.73) and negatively correlated with invasion depth (OR = 0.17, 95%CI: 0.06-0.47), TNM stage (OR = 0.48, 95%CI: 0.27-0.87), and histological grade (OR = 0.40, 95%CI: 0.21-0.77). Confirming these findings, the GEPIA database indicated that high expression of Piezo2 was associated with poor prognosis of disease-free survival in patients with colon adenocarcinoma (HR = 1.6, P = 0.049) and gastric cancer (HR = 1.6, P = 0.017).

Conclusion: Piezo2 may be associated with poor prognosis and clinicopathological parameters in tumor patients.

« Previous Next »
[1]
Stocker, S.D.; Sved, A.F.; Andresen, M.C. Missing pieces of the Piezo1/Piezo2 baroreceptor hypothesis: An autonomic perspective. J. Neurophysiol., 2019, 122(3), 1207-1212.
[http://dx.doi.org/10.1152/jn.00315.2019] [PMID: 31314636]
[2]
Del Rosario, J.S.; Yudin, Y.; Su, S.; Hartle, C.M.; Mirshahi, T.; Rohacs, T. Gi‐coupled receptor activation potentiates Piezo2 currents via Gβγ. EMBO Rep., 2020, 21(5), e49124.
[http://dx.doi.org/10.15252/embr.201949124] [PMID: 32227462]
[3]
Schneider, E.R.; Anderson, E.O.; Feketa, V.V.; Mastrotto, M.; Nikolaev, Y.A.; Gracheva, E.O.; Bagriantsev, S.N. A cross-species analysis reveals a general role for piezo2 in mechanosensory specialization of trigeminal ganglia from tactile specialist birds. Cell Rep., 2019, 26(8), 1979-1987.e3.
[http://dx.doi.org/10.1016/j.celrep.2019.01.100] [PMID: 30784581]
[4]
Etem, E.Ö.; Ceylan, G.G.; Özaydın, S.; Ceylan, C.; Özercan, I.; Kuloğlu, T. The increased expression of Piezo1 and Piezo2 ion channels in human and mouse bladder carcinoma. Adv. Clin. Exp. Med., 2018, 27(8), 1025-1031.
[http://dx.doi.org/10.17219/acem/71080] [PMID: 30010255]
[5]
Yang, H.; Liu, C.; Zhou, R.M.; Yao, J.; Li, X.M.; Shen, Y.; Cheng, H.; Yuan, J.; Yan, B.; Jiang, Q. Piezo2 protein: A novel regulator of tumor angiogenesis and hyperpermeability. Oncotarget, 2016, 7(28), 44630-44643.
[http://dx.doi.org/10.18632/oncotarget.10134] [PMID: 27329839]
[6]
Lou, W.; Liu, J.; Ding, B.; Jin, L.; Xu, L.; Li, X.; Chen, J.; Fan, W. Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer. Aging, 2019, 11(9), 2628-2652.
[http://dx.doi.org/10.18632/aging.101934] [PMID: 31058608]
[7]
Huang, Z.; Sun, Z.; Zhang, X.; Niu, K.; Wang, Y.; Zheng, J.; Li, H.; Liu, Y. Loss of stretch-activated channels, PIEZOs, accelerates non-small cell lung cancer progression and cell migration. Biosci. Rep., 2019, 39(3), BSR20181679.
[http://dx.doi.org/10.1042/BSR20181679] [PMID: 30745454]
[8]
Chen, T.; Zhang, L.J.; Zhang, L.J.; Rong, S.K.; Wang, Z.; Peng, G.Y.; Gong, F.H.; Li, H. Expression and clinical significance of Piezo2 in colorectal cancer. J. Ningxia Med. Uni., 2020, 42(01), 21-24.
[http://dx.doi.org/10.16050/j.cnki.issn1674-6309.2020.01.004]
[9]
Shang, H.; Xu, A.; Yan, H.; Xu, D.; Zhang, J.; Fang, X. PIEZO2 promotes cell proliferation and metastasis in colon carcinoma through the SLIT2/ROBO1/VEGFC pathway. Adv. Clin. Exp. Med., 2023, 32(7), 763-776.
[http://dx.doi.org/10.17219/acem/157515] [PMID: 36753373]
[10]
Liang, T.; Da, M.X. Expression and clinical significance of PIEZO2 in gastric cancer. Comb. Chem. High Throughput Screen., 2023, 26(12), 2194-2200.
[http://dx.doi.org/10.2174/1386207326666230209140929] [PMID: 36757044]
[11]
Huttner, A.; Verhaegh, E.M.; Harbarth, S.; Muller, A.E.; Theuretzbacher, U.; Mouton, J.W. Nitrofurantoin revisited: A systematic review and meta-analysis of controlled trials. J. Antimicrob. Chemother., 2015, 70(9), 2456-2464.
[http://dx.doi.org/10.1093/jac/dkv147] [PMID: 26066581]
[12]
Wiedermann, C.J. Use of hyperoncotic human albumin solution in severe traumatic brain injury revisited—a narrative review and meta-analysis. J. Clin. Med., 2022, 11(9), 2662.
[http://dx.doi.org/10.3390/jcm11092662] [PMID: 35566786]
[13]
Lee, S.H.; Lee, O.S.; Kim, S.T.; Lee, Y.S. Revisiting arthroscopic partial meniscectomy for degenerative tears in knees with mild or no osteoarthritis. Clin. J. Sport Med., 2020, 30(3), 195-202.
[http://dx.doi.org/10.1097/JSM.0000000000000585] [PMID: 29995671]
[14]
Tang, Z.; Kang, B.; Li, C.; Chen, T.; Zhang, Z. GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res., 2019, 47(W1), W556-W560.
[http://dx.doi.org/10.1093/nar/gkz430] [PMID: 31114875]
[15]
DerSimonian, R.; Laird, N. Meta-analysis in clinical trials revisited. Contemp. Clin. Trials, 2015, 45(Pt A), 139-145.
[http://dx.doi.org/10.1016/j.cct.2015.09.002]
[16]
Cheng, L.; Shen, Z.; Zhou, C. Promoter hypermethylation of PIEZO2 is a risk factor and potential clinical biomarker for laryngeal squamous cell carcinoma. Int. J. Clin. Exp. Pathol., 2017, 10(12), 11635-11643.
[PMID: 31966521]
[17]
Zhao, F.; Zhang, L.; Wei, M.; Duan, W.; Wu, S.; Kasim, V. Mechanosensitive ion channel piezo1 signaling in the hall-marks of cancer: structure and functions. Cancers, 2022, 14(19), 4955.
[http://dx.doi.org/10.3390/cancers14194955] [PMID: 36230880]
[18]
Zhu, Z.; Li, W.; Gong, M.; Wang, L.; Yue, Y.; Qian, W.; Zhou, C.; Duan, W.; Han, L.; Li, L.; Wu, Z.; Ma, Q.; Lin, M.; Wang, S.; Wang, Z. Piezo1 act as a potential oncogene in pancreatic cancer progression. Life Sci., 2022, 310, 121035.
[http://dx.doi.org/10.1016/j.lfs.2022.121035] [PMID: 36208662]
[19]
Kim, O.H.; Choi, Y.W.; Park, J.H.; Hong, S.A.; Hong, M.; Chang, I.H.; Lee, H.J. Fluid shear stress facilitates prostate cancer metastasis through Piezo1-Src-YAP axis. Life Sci., 2022, 308, 120936.
[http://dx.doi.org/10.1016/j.lfs.2022.120936] [PMID: 36084759]
[20]
Marshall, K.L.; Saade, D.; Ghitani, N.; Coombs, A.M.; Szczot, M.; Keller, J.; Ogata, T.; Daou, I.; Stowers, L.T.; Bönnemann, C.G.; Chesler, A.T.; Patapoutian, A. PIEZO2 in sensory neurons and urothelial cells coordinates urination. Nature, 2020, 588(7837), 290-295.
[http://dx.doi.org/10.1038/s41586-020-2830-7] [PMID: 33057202]
[21]
Michel, N.; Narayanan, P.; Shomroni, O.; Schmidt, M. Maturational changes in mouse cutaneous touch and piezo2-mediated mechanotransduction. Cell Rep., 2020, 32(3), 107912.
[http://dx.doi.org/10.1016/j.celrep.2020.107912] [PMID: 32697985]
[22]
Pethő, Z.; Najder, K.; Bulk, E.; Schwab, A. Mechanosensitive ion channels push cancer progression. Cell Calcium, 2019, 80, 79-90.
[http://dx.doi.org/10.1016/j.ceca.2019.03.007] [PMID: 30991298]
[23]
Fang, X.Z.; Zhou, T.; Xu, J.Q.; Wang, Y.X.; Sun, M.M.; He, Y.J.; Pan, S.W.; Xiong, W.; Peng, Z.K.; Gao, X.H.; Shang, Y. Structure, kinetic properties and biological function of mechanosensitive Piezo channels. Cell Biosci., 2021, 11(1), 13.
[http://dx.doi.org/10.1186/s13578-020-00522-z] [PMID: 33422128]
[24]
Savadipour, A.; Nims, R.J.; Rashidi, N.; Garcia-Castorena, J.M.; Tang, R.; Marushack, G.K.; Oswald, S.J.; Liedtke, W.B.; Guilak, F. Membrane stretch as the mechanism of activation of PIEZO1 ion channels in chondrocytes. Proc. Natl. Acad. Sci., 2023, 120(30), e2221958120.
[http://dx.doi.org/10.1073/pnas.2221958120] [PMID: 37459546]
[25]
Qiu, X.; Deng, Z.; Wang, M.; Feng, Y.; Bi, L.; Li, L. Piezo protein determines stem cell fate by transmitting mechanical signals. Hum. Cell, 2022, 36(2), 540-553.
[http://dx.doi.org/10.1007/s13577-022-00853-8] [PMID: 36580272]
[26]
Tian, S.; Cai, Z.; Sen, P.; van Uden, D.; van de Kamp, E.; Thuillet, R.; Tu, L.; Guignabert, C.; Boomars, K.; Van der Heiden, K.; Brandt, M.M.; Merkus, D. Loss of lung microvascular endothelial Piezo2 expression impairs NO synthesis, induces EndMT, and is associated with pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol., 2022, 323(5), H958-H974.
[http://dx.doi.org/10.1152/ajpheart.00220.2022] [PMID: 36149769]
[27]
Yang, K.; He, X.; Wu, Z.; Yin, Y.; Pan, H.; Zhao, X.; Sun, T. The emerging roles of piezo1 channels in animal models of multiple sclerosis. Front. Immunol., 2022, 13, 976522.
[http://dx.doi.org/10.3389/fimmu.2022.976522] [PMID: 36177027]
[28]
Radin, I.; Richardson, R.A.; Haswell, E.S. Moss PIEZO homologs have a conserved structure, are ubiquitously expressed, and do not affect general vacuole function. Plant Signal. Behav., 2022, 17(1), 2015893.
[http://dx.doi.org/10.1080/15592324.2021.2015893] [PMID: 34951344]
[29]
Bektas, S.; Kaptan, E. RNA-Seq transcriptome analysis reveals Maackia amurensis leukoagglutinin has antitumor activity in human anaplastic thyroid cancer cells. Mol. Biol. Rep., 2022, 49(10), 9257-9266.
[http://dx.doi.org/10.1007/s11033-022-07759-6] [PMID: 36057880]
[30]
Ye, X.; Xia, Y.; Zheng, Y.; Chen, W.; Chen, Z.; Cheng, Z.; Wang, B. The function of Piezo1 in hepatoblastoma metastasis and its potential transduction mechanism. Heliyon, 2022, 8(9), e10301.
[http://dx.doi.org/10.1016/j.heliyon.2022.e10301] [PMID: 36097495]
[31]
Wang, Y.; Mang, X.; Li, D.; Chen, Y.; Cai, Z.; Tan, F. Piezoeletric cold atmospheric plasma induces apoptosis and autophagy in human hepatocellular carcinoma cells through blocking glycolysis and AKT/mTOR/HIF-1α pathway. Free Radic. Biol. Med., 2023, 208, 134-152.
[http://dx.doi.org/10.1016/j.freeradbiomed.2023.07.036] [PMID: 37543168]
[32]
Qin, X.; Ni, Z.; Jiang, J.; Liu, X.; Dong, X.; Li, M.; Miao, K.; Rao, S.; Zhang, W.; Cai, K. High‐throughput membrane‐anchored proteome screening reveals PIEZO1 as a promising antibody‐drug target for human esophageal squamous cell carcinoma. Cancer Med., 2022, 11(19), 3700-3713.
[http://dx.doi.org/10.1002/cam4.4744] [PMID: 35608274]
[33]
García-Mesa, Y.; Martín-Sanz, R.; García-Piqueras, J.; Cobo, R.; Muñoz-Bravo, S.; García-Suárez, O.; Martín-Biedma, B.; Vega, J.A.; Feito, J. Merkel cell carcinoma display PIEZO2 immunoreactivity. J. Pers. Med., 2022, 12(6), 894.
[http://dx.doi.org/10.3390/jpm12060894] [PMID: 35743679]
[34]
Shin, K.C.; Park, H.J.; Kim, J.G.; Lee, I.H.; Cho, H.; Park, C.; Sung, T.S.; Koh, S.D.; Park, S.W.; Bae, Y.M. The Piezo2 ion channel is mechanically activated by low-threshold positive pressure. Sci. Rep., 2019, 9(1), 6446.
[http://dx.doi.org/10.1038/s41598-019-42492-4] [PMID: 31015490]
[35]
Ni, K.; Zhang, W.; Ni, Y.; Mao, Y.T.; Wang, Y.; Gu, X.P.; Ma, Z.L. Dorsal root ganglia NR2B mediated Epac1 Piezo2 signaling pathway contributes to mechanical allodynia of bone cancer pain. Oncol. Lett., 2021, 21(4), 338.
[http://dx.doi.org/10.3892/ol.2021.12599] [PMID: 33692870]
[36]
Sprowls, S.A.; Lathia, J.D. Breaking down the barrier to medulloblastoma treatment: Piezo2 knockout disrupts the BTB and increases vascular permeability. Neuron, 2023, 111(1), 3-5.
[http://dx.doi.org/10.1016/j.neuron.2022.12.008] [PMID: 36603549]
[37]
Chen, X.; Momin, A.; Wanggou, S.; Wang, X.; Min, H.K.; Dou, W.; Gong, Z.; Chan, J.; Dong, W.; Fan, J.J.; Xiong, Y.; Talipova, K.; Zhao, H.; Chen, Y.X.; Veerasammy, K.; Fekete, A.; Kumar, S.A.; Liu, H.; Yang, Q.; Son, J.E.; Dou, Z.; Hu, M.; Pardis, P.; Juraschka, K.; Donovan, L.K.; Zhang, J.; Ramaswamy, V.; Selvadurai, H.J.; Dirks, P.B.; Taylor, M.D.; Wang, L.Y.; Hui, C.C.; Abzalimov, R.; He, Y.; Sun, Y.; Li, X.; Huang, X. Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity. Neuron, 2023, 111(1), 30-48.e14.
[http://dx.doi.org/10.1016/j.neuron.2022.10.007] [PMID: 36323321]
[38]
Katsuta, E.; Takabe, K.; Vujcic, M.; Gottlieb, P.A.; Dai, T.; Mercado-Perez, A.; Beyder, A.; Wang, Q.; Opyrchal, M. Mechano-sensing channel PIEZO2 enhances invasive phenotype in triple-negative breast cancer. Int. J. Mol. Sci., 2022, 23(17), 9909.
[http://dx.doi.org/10.3390/ijms23179909] [PMID: 36077309]
[39]
Pardo-Pastor, C.; Rubio-Moscardo, F.; Vogel-González, M.; Serra, S.A.; Afthinos, A.; Mrkonjic, S.; Destaing, O.; Abenza, J.F.; Fernández-Fernández, J.M.; Trepat, X.; Albiges-Rizo, C.; Konstantopoulos, K.; Valverde, M.A. Piezo2 channel regulates RhoA and actin cytoskeleton to promote cell mechanobiological responses. Proc. Natl. Acad. Sci., 2018, 115(8), 1925-1930.
[http://dx.doi.org/10.1073/pnas.1718177115] [PMID: 29432180]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy